{
    "title": "RSS Feed Title",
    "link": "https://example.com",
    "description": "RSS Feed Description",
    "lastBuildDate": "2025-01-03T04:53:01.026782",
    "items": [
        {
            "title": "Weekly Tactical Pick | Cello World: This consumer ware player is set to clock accelerated growth",
            "link": "https://www.moneycontrol.com/news/business/stocks/weekly-tactical-pick-cello-world-this-consumer-ware-player-is-set-to-clock-accelerated-growth-12902507.html",
            "description": "The company is diversifying distribution reach and scaling up launches as demand is expected to improve going forward",
            "pubDate": "2025-01-03T03:49:53.380189"
        },
        {
            "title": "Wockhardt shares rally 5% after Indian drug regulator approves Pneumonia antibiotic",
            "link": "https://www.moneycontrol.com/news/business/markets/wockhardt-shares-rally-5-after-antibiotic-for-pneumonia-treatment-approved-by-indian-drug-regulator-12902581.html",
            "description": "Central Drugs Standard Control Organization (CDSCO) approved antibiotic Nafithromycin, sold under Miqnaf brand, as a new treatment for community-acquired bacterial Pneumonia (CABP) in adults.",
            "pubDate": "2025-01-03T04:53:00.469217"
        }
    ]
}